The Patent Finder

Transtech Pharma, Inc.

0 patents currently held · Updated Nov 21, 2026
58 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

Recorded as renamed to VTV Therapeutics LLC (2015)

0
Ending by 2030
none
Next term end

When these terms end

Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

No patent on this record is in force and held under this name now.

Also on record: 58 patents in force now held by others · 88 lapsed for an unpaid fee · 5 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

14 abandoned · 3 no status recorded

Showing 1 to 10 of 17, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
14/686,352Methods of Treatment Using Fusion ProteinsApr 14, 2015Abandoned
14/215,581Ligands for the GLP-1 Receptor and Methods for Discovery ThereofMay 1, 2014Abandoned
13/412,747Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase InhibitorsMar 6, 2012Abandoned
13/270,208Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic AgentsOct 10, 2011Abandoned
12/961,454Dec 6, 2010No status recorded
12/958,237Substituted Azole Derivatives as Therapeutic AgentsDec 1, 2010Abandoned
12/950,967Substituted Azole Derivatives, Compositions, and Methods of UseNov 19, 2010Abandoned
12/899,073Immunoglobulin Fusion Proteins and Methods of MakingOct 6, 2010Abandoned
12/874,455Solid Compositions Comprising an Oxadiazoanthracene Compound and Methods of Making and Using the SameSep 2, 2010Abandoned
12/238,087Sep 25, 2008No status recorded
10 of 17 applications shown.
Pro members see all 17 published applications.
Pro members: see all 17 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited